Skip to main content

Table 1 Production details from the PET-centers in Trondheim and Tromsø

From: Stability evaluation of [18F]FDG: literature study, stability studies from two different PET centres and future recommendations

Production details

Batch

FDG191211015 (Trondheim)

FDG191212016 (Trondheim)

FDG200114004 (Trondheim)

FDG210824 (Tromsø)

FDG210901 (Tromsø)

FDG211012 (Tromsø)

EOB activity (GBq)

160

160

160

175

176

178

Mean target current

47.42

48.8

46.86

41.37

44.96

50.64

Timepoint EOS

07:29:37

07:28:30

07:28:45

07:24:06

07:25:27

07:23:53

Timepoint bulk measurement

07:47:32

07:38:28

07:35:10

07:30:14

07:31:41

07:29:45

Activity in bulk (GBq)

96.06

103,586

99.47

117.14

120.37

108.49

Volume bulk (mL)

19.33

20,33

22.29

21.79

21.49

21.28

Concentration in bulk at EOS (GBq/mL), pre-dilution

5.56

5,43

4,65

5.59

5.83

5.29

Timepoint measured patient vial

08:13:08

08:08:07

08:25:37

07:54:41

07:58:23

07:52:58

Activity patient vial (GBq)

37.09

40.3

36.52

37.21

36.82

38.38

Volume patient vial (mL)

11.7

12.32

12.46

10,7

10,14

10,09

Concentration patient vial at EOS (GBq/mL)

4.17

4.20

4.20

4.22

4.47

4.57

Concentration patient vial at dispensing (GBq/mL)

3.17

3.27

2.93

3.48

3.63

3.80

  1. Pre-dilution is fixed at 1mL